Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.

about

Kidney volume measurement methods for clinical studies on autosomal dominant polycystic kidney disease.

Item

http://www.wikidata.org/entity/Q36384928

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Kidney volume measurement meth ...... ant polycystic kidney disease.

@ast

Kidney volume measurement meth ...... ant polycystic kidney disease.

@en

type

Item

label

Kidney volume measurement meth ...... ant polycystic kidney disease.

@ast

Kidney volume measurement meth ...... ant polycystic kidney disease.

@en

prefLabel

Kidney volume measurement meth ...... ant polycystic kidney disease.

@ast

Kidney volume measurement meth ...... ant polycystic kidney disease.

@en

P1476

Kidney volume measurement meth ...... ant polycystic kidney disease.

@en

P2093

Andrea Remuzzi

http://www.w3.org/2001/XMLSchema#string

Andreas L Serra

http://www.w3.org/2001/XMLSchema#string

Anna Caroli

http://www.w3.org/2001/XMLSchema#string

Kanishka Sharma

http://www.w3.org/2001/XMLSchema#string

Katja Petzold

http://www.w3.org/2001/XMLSchema#string

Le Van Quach

http://www.w3.org/2001/XMLSchema#string

Michela Bozzetto

http://www.w3.org/2001/XMLSchema#string

P2860

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

OsiriX: an open-source software for navigating in multidimensional DICOM images.

Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.

The importance of total kidney volume in evaluating progression of polycystic kidney disease

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.

Sirolimus therapy to halt the progression of ADPKD.

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.

Clinical characteristics and disease predictors of a large Chinese cohort of patients with autosomal dominant polycystic kidney disease

A comparison of ultrasound and magnetic resonance imaging shows that kidney length predicts chronic kidney disease in autosomal dominant polycystic kidney disease

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

P304

e0178488

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0178488

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28558028

http://www.w3.org/2001/XMLSchema#string

P921

autosomal dominant polycystic kidney disease

P932

5448775

http://www.w3.org/2001/XMLSchema#string